Tianjin Ringpu Bio Tech (300119) — Cash Flow Reinvestment Rate
Tianjin Ringpu Bio Tech (300119) has a Cash Flow Reinvestment Rate of 0.22x as of September 2025, reinvesting CN¥23.24 Million (capex CN¥23.24 Million ) from operating cash flow of CN¥105.02 Million. See cash generation quality of Tianjin Ringpu Bio Tech to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tianjin Ringpu Bio Tech Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Tianjin Ringpu Bio Tech across 19 annual periods. For the full cash flow conversion analysis, see Tianjin Ringpu Bio Tech cash flow conversion.
Annual Cash Flow Reinvestment Rate for Tianjin Ringpu Bio Tech (2007–2025)
Year-by-year capital reinvestment analysis for Tianjin Ringpu Bio Tech. See Tianjin Ringpu Bio Tech (300119) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.79x | CN¥531.63 Million | CN¥297.53 Million | CN¥176.10 Million | ▲ +429.0% |
| 2024 | 0.34x | CN¥248.44 Million | CN¥735.55 Million | CN¥185.34 Million | ▼ -68.5% |
| 2023 | 1.07x | CN¥405.46 Million | CN¥378.20 Million | CN¥244.48 Million | ▼ -74.2% |
| 2022 | 4.15x | CN¥1.62 Billion | CN¥389.49 Million | CN¥372.43 Million | ▲ +142.5% |
| 2021 | 1.71x | CN¥655.02 Million | CN¥382.63 Million | CN¥305.88 Million | ▲ +148.8% |
| 2020 | 0.69x | CN¥267.23 Million | CN¥388.44 Million | CN¥259.17 Million | ▼ -37.0% |
| 2019 | 1.09x | CN¥418.70 Million | CN¥383.61 Million | CN¥229.70 Million | ▲ +17.2% |
| 2018 | 0.93x | CN¥162.91 Million | CN¥174.88 Million | CN¥112.45 Million | ▼ -29.9% |
| 2017 | 1.33x | CN¥142.90 Million | CN¥107.57 Million | CN¥108.87 Million | ▼ -52.3% |
| 2016 | 2.78x | CN¥578.12 Million | CN¥207.67 Million | CN¥128.13 Million | ▲ +35.3% |
| 2015 | 2.06x | CN¥463.56 Million | CN¥225.27 Million | CN¥151.10 Million | ▲ +44.3% |
| 2014 | 1.43x | CN¥183.11 Million | CN¥128.37 Million | CN¥183.11 Million | ▼ -49.7% |
| 2013 | 2.84x | CN¥251.60 Million | CN¥88.68 Million | CN¥251.60 Million | ▲ +52.4% |
| 2012 | 1.86x | CN¥167.37 Million | CN¥89.92 Million | CN¥167.37 Million | ▼ -9.1% |
| 2011 | 2.05x | CN¥184.82 Million | CN¥90.29 Million | CN¥184.82 Million | ▲ +383.2% |
| 2010 | 0.42x | CN¥47.79 Million | CN¥112.82 Million | CN¥47.79 Million | ▼ -12.7% |
| 2009 | 0.49x | CN¥31.34 Million | CN¥64.59 Million | CN¥31.34 Million | ▲ +68.0% |
| 2008 | 0.29x | CN¥19.66 Million | CN¥68.07 Million | CN¥19.66 Million | ▼ -67.5% |
| 2007 | 0.89x | CN¥16.99 Million | CN¥19.15 Million | CN¥16.99 Million | — |